No definition available.
Other congenital malformations of nervous system
Q17_OTHER_CONGEN_MALFO_NERVOUS_SYSTEM
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
373 |
4. Check minimum number of eventsNone |
373 |
5. Include endpointsNone |
373 |
6. Filter based on genotype QC (FinnGen only) |
373 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_NERVOUS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q0
- Name in latin
- Aliae malformationes congenitae systematis nervosi
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of nervous system
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the nervous system
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3361 | 2035 | 1322 |
| Only index persons | 2889 | 1839 | 1050 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.04 |
| Only index persons | 0.06 | 0.07 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 19.42 | 24.31 | 11.87 |
| Only index persons | 23.03 | 27.09 | 15.91 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 373 | 300 | 73 |
| Unadjusted period prevalence (%) | 0.09 | 0.10 | 0.03 |
| Median age at first event (years) | 32.35 | 32.57 | 31.43 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 330
- Matched controls
- 3300
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q07.0
ICD-10 Finland
Arnold-Chiari syndrome
+∞
323.0
293
*
ABE50
NOMESCO Finland
Occipitocervical decompression
+∞
100.2
91
*
G95.0
ICD-10 Finland
Syringomyelia and syringobulbia
449.5
41.0
40
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
13.3
37.0
67
62
R51.80
ICD-10 Finland
Headache
5.1
35.4
138
405
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.3
31.8
83
145
Q07.8
ICD-10 Finland
Other specified congenital malformations of nervous system
+∞
28.5
27
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.5
26.9
76
146
N03AX12
ATC
gabapentin; oral
4.9
21.3
77
194
AA1AD
NOMESCO Finland
CT of head and brain
4.4
21.0
86
246
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
13.5
18.5
32
26
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
16.6
18.3
29
19
R42
ICD-10 Finland
Dizziness and giddiness
3.7
17.5
86
285
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.1
17.4
58
133
R20.2
ICD-10 Finland
Paraesthesia of skin
5.4
16.5
51
107
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
22.3
16.2
23
11
G44.2
ICD-10 Finland
Tension-type headache
3.5
15.2
79
272
Q07.9
ICD-10 Finland
Congenital malformation of nervous system, unspecified
+∞
14.7
14
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
12.2
14.0
25
22
Z01.8
ICD-10 Finland
Other specified special examinations
3.0
13.8
93
382
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.3
12.2
66
231
N03AX16
ATC
pregabalin; oral
3.0
12.0
78
311
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.4
11.6
35
71
N06AX21
ATC
duloxetine; oral
3.6
11.6
55
174
M03BX01
ATC
baclofen; systemic
13.3
11.3
19
15
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.4
11.0
55
181
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
113.4
10.5
11
*
A02BC02
ATC
pantoprazole; systemic
2.1
10.1
186
1243
R51
ICD-10 Finland
Headache
3.9
9.9
41
116
N02AX02
ATC
tramadol; systemic, rectal
2.2
9.5
117
649
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
9.4
9
*
G47.3
ICD-10 Finland
Sleep apnoea
3.0
9.2
56
212
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
19.2
9.0
13
7
TAB00
NOMESCO Finland
Lumbar puncture
4.3
8.1
29
72
M03BX02
ATC
tizanidine; oral
1.9
7.6
189
1359
A02BC01
ATC
omeprazole; systemic
2.2
7.2
80
418
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.3
7.2
36
119
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
30.7
7.2
9
*
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.8
7.2
48
192
N03AE01
ATC
clonazepam; systemic
4.2
7.2
26
66
N01
ICPC
Headache
2.2
7.1
77
397
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
7.1
144
955
N03AX11
ATC
topiramate; oral
4.9
6.8
21
45
M54.4
ICD-10 Finland
Lumbago with sciatica
2.4
6.8
58
266
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
6.7
80
429
ZXY02
NOMESCO Finland
Neuropsychologist
23.0
6.7
9
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
6.6
48
202
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.6
107
652
A01
ICPC
Pain general/multiple sites
3.2
6.5
33
111
L01
ICPC
Neck symptom/complaint
2.4
6.4
57
266
XKD00
NOMESCO Finland
Uroflowmetry
3.5
6.3
28
85
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
6.3
6
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
6.1
45
188
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
6.1
81
453
N06AX16
ATC
venlafaxine; oral
2.2
6.1
62
309
M54.5
ICD-10 Finland
Low back pain
1.9
6.1
109
683
SPAT1301
SPAT
No procedures
1.9
6.0
110
691
N02BE01
ATC
paracetamol; systemic, rectal
1.9
6.0
257
2138
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
215
1192
2.90
22.41
9.2
6.2
mmol/l
1.2
1.2
1.08
190
1031
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
200
1091
2.80
21.12
8.9
5.9
mmol/l
1.2
1.2
0.77
184
1017
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
23
26
9.36
18.73
2.8
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
35
67
5.66
17.86
1.5
2.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
18
16
11.77
17.22
1.1
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
128
635
2.55
15.31
2.2
2.1
u/l
238.9
269.9
0.07
121
610
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
12
12.98
15.23
1.4
1.7
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
35
79
4.79
14.82
2.2
2.1
e6/l
78.8
6.5
1.02
26
61
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
35
79
4.79
14.82
2.2
2.2
e6/l
142.4
219.2
0.26
27
65
(3013826) Glucose [Moles/volume] in Serum or Plasma
234
1544
2.38
14.47
6.5
4.3
mmol/l
6.0
6.3
2.19
223
1381
(3016018) Differential panel - Cerebral spinal fluid
21
31
7.12
13.72
1.5
2.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
55
183
3.35
13.65
7.3
7.8
mmol/l
1.0
0.9
0.06
38
139
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
280
2028
2.53
13.62
6.2
6.4
u/l
73.6
78.4
1.20
267
1899
(3023103) Potassium [Moles/volume] in Serum or Plasma
352
2917
4.67
12.64
16.0
9.9
mmol/l
3.9
3.9
0.72
347
2813
(3023410) Appearance of Cerebral spinal fluid
22
38
6.09
12.41
1.4
3.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
351
2917
4.45
12.23
16.3
9.8
mmol/l
139.6
139.6
0.14
346
2824
(3032080) INR in Blood by Coagulation assay
136
771
2.20
11.41
4.1
5.0
inr
1.0
1.1
0.31
41
263
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
315
2507
2.65
10.96
5.1
4.1
pmol/l
14.4
14.4
0.09
296
2318
(3024561) Albumin [Mass/volume] in Serum or Plasma
156
947
2.11
10.87
4.2
4.8
g/l
38.0
37.2
1.53
142
897
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
146
866
2.13
10.80
2.1
1.7
pmol/l
97.9
98.5
0.05
91
453
(3013707) Erythrocyte sedimentation rate by Westergren method
277
2145
2.13
9.30
4.4
3.7
mm/h
8.5
8.9
0.29
263
2003
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
83
414
2.29
9.28
1.4
1.5
pmol/l
123881043.7
22554785.3
0.37
67
368
(40768797) Stomach Pathology biopsy report
69
319
2.43
9.16
1.3
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
339
2871
2.98
9.09
5.9
4.7
mu/l
1.6
1.8
2.39
324
2698
(3044889) 12 lead EKG panel
229
1665
1.97
9.07
3.0
2.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
123
728
2.03
8.83
3.3
2.8
ng/l
17.5
24.0
0.37
58
332
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
188
1292
1.92
8.67
5.2
5.7
umol/l
10.1
11.1
0.30
175
1211
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
357
3172
3.93
7.63
10.1
8.3
u/l
23.2
24.8
1.12
352
3066
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
49
212
2.51
7.45
13.6
7.8
mmol/l
24.4
24.9
0.42
49
212
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
114
697
1.92
7.23
2.4
2.1
mg/l
2.9
2.8
0.33
96
596
(3006315) Basophils [#/volume] in Blood
209
1554
1.78
6.91
6.5
6.0
e9/l
0.0
0.0
0.19
185
1343
(3036481) Cortisol [Moles/volume] in Serum or Plasma
62
308
2.21
6.90
1.8
2.1
nmol/l
385.8
383.4
0.03
53
288
(3001604) Monocytes [#/volume] in Blood
208
1547
1.78
6.85
6.5
6.0
e9/l
0.5
0.5
0.24
184
1341
(3018418) pH of Serum or Plasma
113
701
1.88
6.80
3.5
3.4
ph
7.4
7.4
1.55
20
117
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
121
768
1.85
6.77
3.1
2.4
u/l
51.6
56.5
0.98
110
715
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
20
54
3.86
6.73
2.2
1.9
ug/l
864.9
189.3
0.60
13
46
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
172
1217
1.77
6.68
2.9
2.5
nmol/l
72.8
71.8
0.17
160
1119
(3021960) Folate [Moles/volume] in Serum or Plasma
85
483
1.98
6.63
1.5
1.3
nmol/l
19.4
20.6
0.33
74
417
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
46
208
2.38
6.35
11.5
5.2
mmol/l
1.3
1.2
0.12
31
146
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
284
2344
1.89
6.35
4.4
4.1
mmol/mol
36.6
37.5
1.04
264
2219
(3013115) Eosinophils [#/volume] in Blood
212
1610
1.73
6.27
7.2
6.5
e9/l
0.2
0.2
0.56
196
1425
(3020891) Body temperature
22
67
3.43
6.24
4.6
4.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
49
231
2.29
6.16
8.6
8.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
27
4.95
6.02
1.1
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
228
1779
1.72
6.00
8.6
8.6
e9/l
3.8
4.0
0.54
204
1539
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
135
913
1.75
5.98
4.1
3.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
73
408
1.98
5.92
3.2
3.5
ng/l
475.3
671.7
0.51
57
327
(3019309) Folate [Moles/volume] in Red Blood Cells
62
328
2.07
5.85
1.7
1.5
nmol/l
1049.2
1136.8
0.37
51
257
(3015377) Calcium [Moles/volume] in Serum or Plasma
125
832
1.76
5.83
2.0
2.8
mmol/l
2.4
2.4
0.16
112
751
(3019198) Lymphocytes [#/volume] in Blood
211
1620
1.70
5.82
6.7
5.9
e9/l
2.1
2.1
0.23
191
1434
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
99
615
1.83
5.82
1.7
2.1
mg/l
0.8
1.0
0.36
68
433
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
47
223
2.27
5.82
1.1
1.2
—
29.9
—
0
9
(3019060) Gas panel - Arterial blood
26
92
2.96
5.80
7.8
4.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
132
902
1.72
5.56
2.6
2.0
—
—
—
0
0
(4027681)
13
29
4.61
5.55
1.2
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
15
38
4.07
5.49
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
306
2629
1.91
5.49
3.9
3.3
mmol/l
5.6
5.6
0.00
286
2449
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
108
702
1.76
5.42
2.6
2.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
49
245
2.15
5.34
5.7
5.0
—
—
—
0
0
(3026782) Osmolality of Urine
85
518
1.83
5.28
3.5
2.5
mosm/kgh2o
526.0
592.8
1.56
75
442
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
36
4.00
5.03
1.0
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
345
3121
2.40
4.99
15.8
10.1
mg/l
16.0
19.8
2.00
298
2338
(3019069) Monocytes/100 leukocytes in Blood
191
1478
1.60
4.74
7.0
6.2
%
7.9
7.9
0.14
181
1396
(3006504) Eosinophils/100 leukocytes in Blood
189
1463
1.59
4.66
6.8
6.0
%
2.7
2.8
0.31
178
1371
(40761511) CBC panel - Blood by Automated count
358
3310
3.03
4.65
14.3
9.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
210
1678
1.58
4.43
3.5
2.9
ug/l
69.2
64.6
0.18
202
1572
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
133
956
1.61
4.42
3.6
3.2
u/l
26.8
28.4
0.51
125
913
(3022096) Basophils/100 leukocytes in Blood
182
1409
1.57
4.40
7.1
6.1
%
0.6
0.7
0.97
171
1324
(3023368) Bacteria identified in Blood by Culture
82
522
1.73
4.34
4.1
3.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
118
830
1.62
4.26
3.5
2.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
48
261
1.96
4.19
8.8
5.2
mmol/l
1.9
1.6
0.35
39
195
(3018010) Neutrophils/100 leukocytes in Blood
193
1529
1.54
4.12
6.6
5.7
%
53.4
55.2
1.22
182
1446
(40760892) CBC W Ordered Manual Differential panel - Blood
108
750
1.62
4.09
5.1
4.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
49
272
1.92
4.03
1.4
1.7
iu/l
21.2
19.6
0.11
41
226
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
61
364
1.81
4.01
1.9
2.2
mmol/l
2.4
2.4
0.42
54
316
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
246
2069
1.56
3.91
3.7
2.9
u/l
33.3
33.5
0.02
235
1979
(3000850) Epithelial cells [#/volume] in Urine
84
553
1.67
3.91
3.7
2.4
e6/l
5.6
9.1
1.36
76
481
(3019150) Specific gravity of Urine by Refractometry
96
657
1.62
3.83
4.5
3.1
kg/l
1.0
1.0
0.37
15
89
(3029937) Albumin [Presence] in Urine by Test strip
112
800
1.57
3.73
4.9
3.3
estimate
0.0
0.0
0.50
43
314
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
41
220
1.97
3.72
2.1
3.0
g/l
0.2
0.2
0.58
35
214
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
83
554
1.64
3.65
1.3
1.3
iu/ml
16.8
25.2
0.88
26
159
(3002030) Lymphocytes/100 leukocytes in Blood
192
1547
1.50
3.62
6.8
5.9
%
31.9
30.9
0.66
178
1462
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
53
314
1.80
3.57
1.3
1.3
iu/ml
117.3
156.0
0.46
19
129
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
179
1425
1.49
3.56
4.3
3.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
39
213
1.93
3.38
2.6
2.1
e9/l
3.7
4.1
0.58
30
180
(3013512) EKG study
83
567
1.60
3.30
3.1
2.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
66
426
1.67
3.29
3.3
2.7
e6/l
1.1
0.9
0.27
40
229
(3037467) Urinalysis macro (dipstick) panel - Urine
247
2120
1.49
3.24
5.4
3.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
147
1142
1.47
3.22
4.9
3.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
33
3.40
3.21
1.4
4.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
25
118
2.20
3.18
1.6
2.9
ng/l
81.1
121.4
0.50
20
107
(36304419) Bacteria [Presence] in Urine
104
756
1.52
3.14
4.1
2.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
56
2.75
3.09
2.3
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
183
1493
1.44
3.06
4.7
3.1
estimate
0.0
0.0
0.00
42
312
(3030467) Casts [#/volume] in Urine by Automated count
101
736
1.51
3.00
4.3
3.0
e6/l
0.3
0.3
0.01
80
546
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
130
998
1.46
2.98
1.4
1.4
u/ml
0.9
2.1
1.27
36
248
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
291
2605
1.53
2.93
10.7
8.3
ml/min/173m2
99.8
95.9
2.56
251
2030
(3022313) Gas panel - Capillary blood
32
172
1.94
2.92
13.7
5.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
36
202
1.87
2.89
4.1
4.0
%
0.0
0.5
—
8
41
(3026493) Urate [Moles/volume] in Serum or Plasma
81
568
1.54
2.86
1.9
2.8
umol/l
299.6
4193.3
1.82
71
503
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
30
159
1.96
2.85
3.6
4.1
mmol/l
1.2
1.2
0.36
23
136
(42870588) Differential panel, method unspecified - Blood
131
1017
1.44
2.80
7.5
6.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
37
212
1.83
2.79
6.3
4.1
%
0.0
0.7
—
9
57
(3004588) Protein electrophoresis panel - Serum or Plasma
20
91
2.27
2.79
2.8
2.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
75
520
1.55
2.78
2.6
2.4
ug/g
97.0
82.1
0.32
54
397
(3021589) Normoblasts [#/volume] in Blood
175
1435
1.41
2.76
10.2
7.8
e9/l
0.0
0.0
0.29
142
1158
(3021440) Promyelocytes/100 leukocytes in Blood
35
198
1.85
2.75
6.6
4.2
%
0.0
0.1
—
8
49
(3015736) pH of Urine
148
1180
1.42
2.72
4.2
2.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
43
261
1.73
2.69
2.1
2.4
u/l
24.3
32.1
1.22
38
214
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
55
357
1.63
2.68
1.9
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
55
2.61
2.64
2.1
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
61
408
1.59
2.64
3.6
2.8
e6/l
4.9
3.4
0.53
36
212
(40761535) Cells panel - Urine sediment
31
171
1.89
2.64
3.5
3.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
15
4.73
2.61
1.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
35
202
1.81
2.59
2.8
4.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
183
1524
1.39
2.58
4.9
3.2
estimate
0.0
0.0
0.00
44
304
(3018738) Hemoglobin F/Hemoglobin.total in Blood
5
7
7.22
2.55
1.8
2.9
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
43
266
1.70
2.52
1.4
1.2
u/ml
137.6
260.1
0.59
37
242
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
26
3.52
2.49
1.8
4.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
107
816
1.44
2.48
4.6
2.9
e6/l
16.6
62.8
2.68
85
614
(3021601) Nitrite [Presence] in Urine by Test strip
180
1503
1.38
2.46
6.4
4.4
estimate
0.0
0.0
0.50
39
318
(3025159) Blasts/100 leukocytes in Blood
33
191
1.80
2.43
6.9
4.2
%
0.0
0.0
—
6
42
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
34
2.99
2.43
1.0
1.4
nmol/l
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
299
2726
1.49
2.43
3.9
3.5
mmol/l
2.8
2.8
0.13
279
2566
(3037522) Nuclear Ab [Titer] in Serum
66
460
1.53
2.39
1.4
1.4
titre
494.5
494.9
0.00
11
91
(3018095) Leukocytes [#/volume] in Urine
129
1028
1.39
2.31
5.0
3.4
e6/l
57.3
56.4
0.01
94
665
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
8
23
3.53
2.28
6.9
4.9
ug/l
1.7
1.6
—
8
23
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
138
1117
1.37
2.24
2.1
1.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
9
5.61
2.22
1.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
9
5.61
2.22
2.6
2.8
nmol/l
55.0
55.1
—
5
9
(3007164) IgA [Mass/volume] in Serum or Plasma
111
868
1.40
2.21
1.8
1.5
g/l
1.8
2.0
1.10
70
513
(3040151) Glucose [Moles/volume] in Capillary blood
8
24
3.38
2.19
1.4
1.5
mmol/l
5.7
5.7
—
8
18
(3011397) Hemoglobin [Presence] in Urine by Test strip
91
690
1.42
2.16
4.4
3.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
43
2.61
2.11
10.5
4.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
38
241
1.64
2.05
1.6
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
38
241
1.64
2.05
1.6
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
126
1.88
2.03
1.8
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
21
3.38
1.97
1.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
8
27
3.00
1.94
1.6
1.5
pmol/l
512.8
468.5
—
8
20
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
60
429
1.48
1.93
2.2
1.6
%
1.3
1.3
0.04
54
389
(4010399)
26
151
1.78
1.92
1.3
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
50
345
1.52
1.91
1.6
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
43
287
1.56
1.90
2.1
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
302
2801
1.41
1.85
4.0
4.0
—
—
—
0
0
(4034850)
16
80
2.04
1.82
7.6
7.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
43
290
1.55
1.82
2.1
1.7
—
—
—
0
0
(4062490)
9
35
2.61
1.81
1.4
1.2
—
—
—
0
0
(4024509)
7
23
3.08
1.80
1.0
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
293
2708
1.38
1.80
3.6
3.3
mmol/l
4.6
4.7
0.28
277
2565
(3028300) Cannabinoids [Presence] in Urine
43
291
1.54
1.80
2.1
1.7
—
—
—
0
0
(4094501)
11
47
2.38
1.79
1.1
1.0
—
—
—
0
0
(1002224) Polysomnography panel
22
125
1.81
1.76
1.0
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
18
3.37
1.75
2.0
2.8
nmol/l
1.4
2.6
—
6
18
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
61
2.17
1.73
1.2
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
34
220
1.60
1.72
1.5
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
291
2694
1.36
1.71
3.5
3.3
mmol/l
1.5
1.5
0.07
272
2540
(3028707) Methadone [Presence] in Urine by Screen method
23
134
1.76
1.70
2.8
2.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
280
2578
1.35
1.70
3.3
3.0
mmol/l
1.2
1.2
0.12
262
2431
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
72
548
1.39
1.66
1.3
1.3
u/ml
4.7
9.7
0.73
27
216
(3009508) Creatinine [Moles/volume] in Urine
87
683
1.36
1.66
3.7
3.5
mmol/l
7.2
8.3
1.24
79
592
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
14
3.60
1.62
1.8
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
5
14
3.60
1.62
2.6
2.1
e9/l
0.2
0.2
—
5
14
(3011648) Oxygen content in Venous blood
6
20
3.03
1.58
18.5
8.2
%
13.6
11.3
—
6
20
(3035637) Corticotropin [Mass/volume] in Plasma
11
50
2.24
1.58
1.3
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
93
1.87
1.54
2.4
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
18
304
0.57
1.53
1.6
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
51
372
1.43
1.50
2.5
2.4
u/l
4426.7
3336.4
0.12
14
158
(1001926) Buprenorphine [Presence] in Urine by Screen method
34
228
1.54
1.50
2.2
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
68
522
1.37
1.50
1.7
1.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
37
2.47
1.49
12.7
5.2
%
70.2
63.1
—
9
37
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
87
1.88
1.48
10.8
10.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
327
3105
1.43
1.48
15.6
11.1
%
40.3
40.1
0.24
254
2614
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
16
3.15
1.44
1.0
1.1
miu/ml
1562.8
1631.1
—
5
16
(40758558) Short blood count panel - Blood
95
772
1.31
1.43
6.5
6.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
31
206
1.55
1.43
1.4
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
15
81
1.89
1.42
1.8
1.7
u/ml
89.0
116.0
—
7
14
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
29
2.44
1.40
1.0
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
29
191
1.56
1.39
1.3
1.8
u/l
8.1
9.5
0.28
21
152
(3003740) Influenza virus B Ag [Presence] in Specimen
17
97
1.79
1.37
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
17
97
1.79
1.37
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
17
2.97
1.36
2.0
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
14
75
1.90
1.36
2.6
2.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
42
2.17
1.34
1.8
3.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
40
287
1.44
1.30
2.2
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
132
1133
1.26
1.28
2.0
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
24
358
0.65
1.25
1.4
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
36
2.25
1.25
2.1
1.5
—
—
—
0
0
(4198724)
6
25
2.42
1.25
1.3
2.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
108
1.70
1.24
1.2
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
28
189
1.52
1.23
2.5
2.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
37
2.19
1.22
1.1
1.4
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
5
19
2.65
1.22
1.2
1.4
%
75.2
75.8
—
5
19
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
5
19
2.65
1.22
1.2
1.4
mu/l
683.0
468.3
—
5
19
(3007853) Bacteria identified in Skin by Aerobe culture
45
335
1.39
1.21
1.7
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
105
883
1.26
1.21
4.2
2.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
25
166
1.54
1.18
2.8
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
37
267
1.43
1.18
1.5
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
110
1.67
1.17
1.7
2.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
81
662
1.29
1.17
1.5
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
20
126
1.62
1.17
1.3
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
15
87
1.75
1.17
1.8
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
52
400
1.35
1.15
3.3
2.9
ng/l
26.6
354.9
3.31
26
218
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
11
58
1.92
1.13
12.2
4.0
%
1.7
1.4
0.53
11
53
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
13
73
1.81
1.12
1.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
128
1.59
1.11
1.7
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
81
1.76
1.10
1.1
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
24
161
1.52
1.10
1.9
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
18
277
0.63
1.10
1.4
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
32
438
0.71
1.09
1.1
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
79
650
1.27
1.08
2.0
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
32
2.21
1.08
2.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
216
0.59
1.08
1.5
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
17
105
1.65
1.08
1.8
2.1
iu/l
9.6
6.2
—
7
36
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
82
1.73
1.06
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
33
2.14
1.06
1.7
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
49
379
1.34
1.05
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
130
1.57
1.05
1.3
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
75
1.76
1.04
1.1
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
22
2.29
1.03
1.4
1.7
g/l
0.8
1.0
—
5
22
(3049717) Cytology report of Urine Cyto stain
9
48
1.90
1.01
1.3
1.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
35
2.02
1.00
2.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
35
2.02
1.00
2.0
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
41
531
0.74
1.00
1.5
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
36
268
1.38
0.99
2.3
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
14
222
0.62
0.98
1.4
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
29
0.00
0.98
0.0
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
36
1.96
0.97
2.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
36
1.96
0.97
2.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
36
1.96
0.97
2.0
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
36
1.96
0.97
2.4
4.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
36
1.96
0.97
2.0
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
28
200
1.43
0.97
1.3
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
118
0.50
0.95
2.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
27
2.24
0.94
1.5
1.7
%
93.3
92.3
—
6
27
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
19
278
0.67
0.94
1.4
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
9
52
1.75
0.93
1.2
1.7
g/l
38.9
39.0
—
9
47
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
19
277
0.67
0.92
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
19
277
0.67
0.92
1.4
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
23
160
1.47
0.91
5.1
3.9
%
21.4
21.1
—
10
58
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
63
1.77
0.91
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
63
1.77
0.91
1.5
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
63
1.77
0.91
1.6
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
26
186
1.43
0.90
1.1
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
29
2.09
0.89
1.2
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
14
216
0.63
0.89
1.4
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
56
1.81
0.88
1.2
1.7
g/l
11.5
10.5
—
10
51
(3030981) Hyaline casts [#/volume] in Urine by Automated count
18
120
1.53
0.87
3.8
1.9
e6/l
0.1
0.1
0.13
18
114
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
44
1.84
0.86
1.5
2.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
31
1.95
0.84
1.5
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
130
1.49
0.82
1.3
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
18
258
0.68
0.82
1.4
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
48
1.68
0.79
2.0
1.7
%
12.9
13.2
—
8
48
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
27
0.00
0.77
0.0
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
107
1.52
0.77
1.8
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
34
1.78
0.76
1.8
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
59
1.71
0.76
1.6
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
35
272
1.32
0.76
3.1
3.3
%
32.2
31.4
0.18
28
188
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
54
1.68
0.75
3.2
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
25
2.01
0.73
1.6
2.7
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
5
27
1.86
0.68
1.0
1.0
u/ml
—
0.1
—
0
8
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.4
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
102
1.49
0.68
2.0
2.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
304
2934
1.20
0.65
17.7
12.7
g/l
332.6
333.2
0.65
304
2914
(3012516) Albumin [Mass/volume] in Urine
56
473
1.22
0.64
3.9
3.5
mg/l
1166.4
90.9
0.45
38
315
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
15
104
1.46
0.63
1.8
1.7
u/ml
242.7
214.5
—
9
60
(3020682) Albumin/Creatinine [Ratio] in Urine
58
493
1.21
0.62
4.2
4.3
mg/mmol
4.2
14.5
1.93
36
318
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
14
96
1.48
0.62
1.4
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
34
272
1.28
0.62
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
36
1.68
0.57
1.8
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
6
37
1.63
0.56
2.0
1.3
pmol/l
170.7
210.0
—
6
37
(3045414) Leukocytes [Presence] in Urine
16
116
1.40
0.55
1.4
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
29
232
1.27
0.54
3.7
3.7
pmol/l
4.6
4.8
0.59
29
209
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
40
1.51
0.52
1.5
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
75
1.48
0.51
1.6
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
156
0.70
0.51
1.5
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
36
299
1.23
0.50
4.1
3.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
67
1.51
0.50
1.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
63
554
1.17
0.48
1.8
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
7
47
1.50
0.48
2.4
3.1
kpa
9.8
9.6
—
7
47
(3013290) Carbon dioxide [Partial pressure] in Blood
7
47
1.50
0.48
2.4
3.1
kpa
4.8
4.9
—
7
47
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
85
1.43
0.47
2.7
2.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
210
1.26
0.46
2.8
2.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
36
303
1.21
0.45
1.4
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
13
95
1.38
0.44
1.6
1.7
iu/ml
0.0
0.0
—
8
12
(44813793)
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
2.8
1.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
16
0.00
0.41
0.0
3.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
60
1.34
0.40
3.3
4.1
%
55.9
56.0
—
8
60
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
60
1.34
0.40
3.1
4.0
e9/l
4.1
4.2
—
8
60
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
18
0.00
0.40
0.0
1.0
—
100.7
—
0
10
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
18
0.00
0.40
0.0
1.0
—
134.8
—
0
18
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
14
106
1.33
0.39
14.9
11.2
mg/l
1.2
1.1
0.08
14
101
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
18
225
0.79
0.39
2.2
1.7
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
19
0.00
0.39
0.0
1.0
—
94.8
—
0
11
(3008037) Lactate [Moles/volume] in Venous blood
5
36
1.39
0.38
4.2
2.4
mmol/l
1.5
1.2
—
5
36
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
91
987
0.90
0.37
1.9
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
37
1.36
0.37
1.0
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
72
1.40
0.37
3.5
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
16
201
0.79
0.36
1.6
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
41
1.47
0.36
1.0
3.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
15
117
1.29
0.35
1.2
1.5
—
10.1
—
0
5
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
117
1.29
0.35
1.3
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
42
1.44
0.35
1.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
42
1.44
0.35
1.3
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
73
1.38
0.35
2.7
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
12
91
1.33
0.34
1.3
1.2
—
1.8
—
0
7
(42529406) Shigella sp [Presence] in Stool by Culture
15
118
1.28
0.34
1.3
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
92
1.31
0.32
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
73
670
1.11
0.31
1.5
1.6
mmol/l
1.3
1.4
0.20
65
591
(3022145) Colonoscopy Study observation
30
260
1.17
0.30
1.5
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
7
56
1.25
0.29
3.4
1.7
ug/l
0.5
6.7
—
7
51
(3019832) Treponema pallidum Ab [Presence] in Serum
80
860
0.91
0.28
1.8
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
258
0.84
0.28
1.6
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
46
416
1.12
0.26
1.8
2.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
72
1.26
0.26
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
123
1.23
0.25
1.8
1.3
—
—
—
0
0
(3000492) Spirometry study
31
275
1.14
0.24
1.4
1.4
—
—
—
0
0
(4035726)
22
190
1.17
0.23
1.7
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
106
1.23
0.23
3.8
2.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.4
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
116
1.21
0.22
1.4
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
10
0.00
0.21
0.0
1.4
—
26.2
—
0
10
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
12
0.00
0.21
0.0
3.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
43
1.16
0.21
1.4
1.5
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.0
—
2.8
—
0
13
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
72.6
—
0
13
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
9.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.5
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
4.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
0.3
—
0
7
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
4.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
105
1002
1.07
0.20
2.7
2.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
70
1.15
0.16
1.4
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
206
1.12
0.16
1.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
12
140
0.85
0.15
1.0
1.1
—
6.2
—
0
18
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
17
190
0.89
0.13
2.1
2.2
u/ml
16.3
48.2
1.54
17
180
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
96
926
1.05
0.13
2.7
2.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
22
201
1.10
0.11
1.3
1.4
miu/ml
247.7
258.4
0.05
12
100
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
19
173
1.10
0.10
4.4
2.5
ml/min/173m2
55.2
82.6
—
6
65
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
2.8
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
34
321
1.07
0.09
1.1
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
55
1.09
0.09
1.3
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
12
107
1.13
0.08
2.3
6.2
g/l
0.1
0.4
—
5
60
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
63
0.79
0.08
1.4
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
65
1.08
0.08
1.4
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
70
0.85
0.07
1.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
36
343
1.05
0.07
1.6
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
186
1.08
0.07
1.4
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
121
1232
0.97
0.06
2.1
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
117
1149
1.03
0.06
1.7
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
85
831
1.03
0.06
1.8
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
149
1.08
0.05
1.4
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
149
0.94
0.03
1.5
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
25
260
0.96
0.03
1.6
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
128
0.94
0.02
1.8
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
25
253
0.99
0.00
1.1
1.2
—
105.6
—
0
8
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
145
1.04
0.00
1.3
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
275
1.02
0.00
1.5
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
16
164
0.97
0.00
1.6
1.7
mg/l
2.4
2.8
—
9
110
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
35
354
0.99
0.00
1.7
1.4
—
—
—
0
0
(4306422)
5
50
1.00
0.00
1.2
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
50
1.00
0.00
1.0
1.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
7
71
0.99
0.00
1.4
1.9
mg/l
6.9
9.6
—
7
65
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
90
1.00
0.00
1.4
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
38.0
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
109
1090
1.00
0.00
2.1
2.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
7.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
83
0.96
0.00
2.0
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
63
0.95
0.00
1.0
2.3
nmol/l
1.5
0.9
—
6
57
(3045788) Cell count panel - Pleural fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
7.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
62
0.97
0.00
2.8
2.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
89
1.01
0.00
1.1
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
9.4
—
0
6
(40765096) Chromosome analysis panel by Banding
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_NERVOUS_SYSTEM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_NERVOUS_SYSTEM | 1.466 [1.11, 1.94] | 0.008 |
| Birth year | 1.002 [0.99, 1.01] | 0.727 |
During the follow-up period (1.1.1998 — 31.12.2019), 59 out of 1703 females with Q17_OTHER_CONGEN_MALFO_NERVOUS_SYSTEM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_NERVOUS_SYSTEM | 2.062 [1.43, 2.98] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 52 out of 1152 males with Q17_OTHER_CONGEN_MALFO_NERVOUS_SYSTEM died.
Mortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_NERVOUS_SYSTEM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.184% | 0.435% |
| 5 | 1.029% | 2.466% |
| 10 | 2.689% | 5.886% |
| 15 | 4.951% | 11.231% |
| 20 | 8.946% | 18.364% |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_NERVOUS_SYSTEM – Other congenital malformations of nervous system
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data